CBS 2019
CBSMD教育中心
中 文

急性冠脉综合征

Abstract

Recommended Article

Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Coronary Syndrome A randomised trial comparing two stent sizing strategies in coronary bifurcation treatment with bioresorbable vascular scaffolds - The Absorb Bifurcation Coronary (ABC) trial Incidence and Outcomes of Acute Coronary Syndrome After Transcatheter Aortic Valve Replacement Fractional flow reserve vs. angiography in guiding management to optimize outcomes in non-ST-segment elevation myocardial infarction: the British Heart Foundation FAMOUS-NSTEMI randomized trial 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Ca Circulating MicroRNAs and Monocyte-Platelet Aggregate Formation in Acute Coronary Syndrome Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes Early versus delayed invasive intervention in acute coronary syndromes

Review Article2020 Jun 27;9(7):E2020.

JOURNAL: J Clin Med . Article Link

Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Coronary Syndrome

W Bor, DA Gorog. Keywords: NOAC; ACS; antiplatelet therapy; antithrombotic therapy; atrial fibrillation; dual therapy; oral anticoagulants; percutaneous coronary intervention; triple therapy; vitamin K antagonist

Full Text PDF